A Phase 1/2 Study of HS-10365 in Advanced Solid Tumors
Recruiting Phase 1,Phase 2 NCT05207787
Study Description
A Clinical Trial to Investigate the Safety and Effectiveness of an Experimental Drug (HS-10365) for the Treatment of Advanced Solid Tumors with RET Alterations
Study Details
- Registry ID:
- NCT05207787
- Conditions:
- Solid Tumor
- Phase:
- Phase 1,Phase 2
- Target Enrollment:
- 306 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Shanghai Chest Hospital
Shanghai, Shanghai, China
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.